SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-036860
Filing Date
2024-08-13
Accepted
2024-08-13 08:03:55
Documents
73
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ovid-20240630.htm   iXBRL 10-Q 1258422
2 EX-31.1 ovid2024q2exhibit311.htm EX-31.1 10722
3 EX-31.2 ovid2024q2exhibit312.htm EX-31.2 10759
4 EX-32.1 ovid2024q2exhibit321.htm EX-32.1 6003
10 ovid-20240630_g1.gif GRAPHIC 58249
  Complete submission text file 0001628280-24-036860.txt   6506948

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovid-20240630.xsd EX-101.SCH 48584
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ovid-20240630_cal.xml EX-101.CAL 62052
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ovid-20240630_def.xml EX-101.DEF 178090
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ovid-20240630_lab.xml EX-101.LAB 603227
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovid-20240630_pre.xml EX-101.PRE 405833
76 EXTRACTED XBRL INSTANCE DOCUMENT ovid-20240630_htm.xml XML 730819
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38085 | Film No.: 241198854
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)